PHARMADES
0470.991.418 · rovalta.com · 09/11/2026
PHARMADES
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMADES is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Stabroek. It employs on average 1,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0470.991.418
- Incorporation
- 18/02/2000
- Legal form
- Public limited company
- Registered office
- Conservenweg 13d
2940 Stabroek · FlandreSee on map - Contributed capital
- 75 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,7 ETP
Joint committees (5)
- 200
- 207
- 20700
- 31300
- 321
Financials
Source · NBB, 20 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 224,9 k € | -9.9% | 249,7 k € | -30.2% | 357,5 k € | -9.3% | 393,9 k € | -5.9% | 418,4 k € |
| EBITDA | 94,8 k € | -25.1% | 126,5 k € | -43.6% | 224,5 k € | -20.3% | 281,5 k € | -9.2% | 310,1 k € |
| Operating result | 93,5 k € | -0.3% | 93,8 k € | -55.1% | 208,9 k € | -21.0% | 264,3 k € | -9.3% | 291,5 k € |
| Net result | 79,3 k € | +8.0% | 73,4 k € | -52.6% | 154,7 k € | -17.9% | 188,5 k € | -9.8% | 209 k € |
| Balance sheet | |||||||||
| Equity | 1,3 M € | +6.3% | 1,3 M € | +6.2% | 1,2 M € | +15.1% | 1 M € | +22.5% | 835,9 k € |
| Total assets | 1,4 M € | +0.8% | 1,4 M € | +1.2% | 1,4 M € | +15.2% | 1,2 M € | -14.2% | 1,4 M € |
| Cash | 49,1 k € | -73.4% | 184,7 k € | -57.9% | 439 k € | +17.2% | 374,5 k € | -26.7% | 511 k € |
| Debts | 76,5 k € | -46.9% | 144 k € | -28.5% | 201,4 k € | +15.6% | 174,2 k € | -69.0% | 561,1 k € |
| Other | |||||||||
| Workforce | 1,7 ETP | -19.0% | 2,1 ETP | 0.0% | 2,1 ETP | +110% | 1,0 ETP | -44.4% | 1,8 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Elisabeth Marta César MATTHEUSSENS | Managing director04/01/2016 → 2018 accounts | ||
Elisabeth Martha César Mattheussens | Managing director04/01/2016 → 2021 accounts | ||
Joannes Ludovicus Mattheussens | Managing director04/01/2016 → 2024 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/10/2026 | 07/04/2025 | 30/05/2024 | 30/05/2023 | 23/06/2022 | 30/06/2021 |
| General meeting | 28/05/2026 | 07/04/2025 | 30/05/2024 | 25/05/2023 | 27/05/2022 | 27/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 28/05/2026 | 14/10/2026 | Dutch | |
| Abridged model | 31/12/2024 | 07/04/2025 | 07/04/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/05/2024 | 30/05/2024 | Dutch | |
| Abridged model | 31/12/2022 | 25/05/2023 | 30/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 23/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 27/05/2021 | 30/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 28/05/2020 | 10/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/05/2019 | 26/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 31/05/2018 | 04/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 01/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 09/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 28/05/2015 | 03/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 29/05/2014 | 16/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/05/2013 | 05/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 06/07/2012 | 24/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 26/05/2011 | 24/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 27/05/2010 | 03/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 28/05/2009 | 26/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/06/2008 | 31/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 31/10/2007 | 29/11/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Elisabeth Marta César MATTHEUSSENS | Managing director04/01/2016 → 2018 accounts | ||
Elisabeth Martha César Mattheussens | Managing director04/01/2016 → 2021 accounts | ||
Joannes Ludovicus Mattheussens | Managing director04/01/2016 → 2024 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates02/01/2026ONTSLAGEN - BENOEMINGEN
- Mandates15/07/2022ONTSLAGEN - BENOEMINGEN
- Mandates22/06/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Registered office12/01/2018Verplaatsing maatschappelijke zetel
- Mandates07/04/2016Ontslag en benoeming (gedelegeerde) bestuurders !
- Mandates27/08/2012ONTSLAGEN - BENOEMINGEN
- Mandates07/11/2006BENOEMING EN HERBENOEMING BESTUURDERS !
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Conservenweg 13d, 2940 StabroekCurrent | CBE | |
| Conservenweg 13, 2940 Stabroek | accounts 2021 → 2025 | Accounts 2025 · 2026-00557007 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMADESCurrent | accounts 2006 → 2025 | Accounts 2025 · 2026-00557007 |
Events
- 2025Annual accounts 202579,3 k €↑
- 2024Annual accounts 202473,4 k €↓
- 2023Annual accounts 2023154,7 k €↓
- 2022Annual accounts 2022188,5 k €↓
- 2021Annual accounts 2021209 k €↑
- 2018Annual accounts 201865,8 k €↓
- 2017Annual accounts 201770,3 k €↓
- 2016Annual accounts 2016169,9 k €↑
- 2015Annual accounts 201551,1 k €↓
- 2014Annual accounts 2014126,8 k €↓
- 2013Annual accounts 2013281,2 k €↓
- 2012Annual accounts 2012348,5 k €↑
- 2011Annual accounts 20117,1 k €↓
- 2010Annual accounts 201015,8 k €↑
- 2009Annual accounts 2009-38,2 k €↓
- 2008Annual accounts 2008206,4 k €↑
- 2007Annual accounts 2007-19,6 k €↑
- 2006Annual accounts 2006-421,7 k €
- 18/02/2000IncorporationPublic limited company